13F filing recap · Q3 2024
What did Oaktree Capital Management buy in Q3 2024?
Reported stock-position changes between this filing and the previous one.
Stock value
$5.31B
Positions
58
Estimated turnover
19.3%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Oaktree Capital Management opened new positions in Talen Energy Corporation, California Resources Corp, Yum China Holdings, Pdd Holdings, Infosys, Enlink Midstream, Kanzhun, Netease, Daqo New Energy, and Xp Inc. It exited Azul, Gerdau, and Star Holdings. The firm substantially increased its stake in Liberty Global and dramatically added to Indivior Pharmaceuticals, while substantially trimming Vale, Jd.com, Bank Bradesco, and Ypf Sociedad Anonima.